Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

1(20.0%)

Phase 1

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 4(1)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01228682Unknown

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

Role: lead

NCT00781638Not ApplicableCompleted

ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

Role: lead

NCT00773630Phase 1Completed

A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

Role: lead

NCT00366925Not ApplicableCompleted

CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis

Role: lead

NCT00219414Phase 4Completed

Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)

Role: lead

NCT00401271Phase 2Completed

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Role: lead

All 6 trials loaded